Trials / Completed
CompletedNCT05883150
Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment
Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment: A Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Nourhan M.Aly · Academic / Other
- Sex
- All
- Age
- 3 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the current study is to compare the effect of intranasal versus nebulized route of administration of midazolam as moderate sedative agents in preschoolers undergoing dental treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nebulized Midazolam | All the drug solutions will be freshly prepared on the day of sedation session. Depending on the dosage calculated from the weight of each child The sedative drug, the dosage will be diluted with an equal volume by adding distilled water. The child will be seated in an upright position on the dental chair. Before placing the mask of the nebulizer, the child will be coached into proper breathing pattern |
| DRUG | Intranasal Midazolam | All the drug solutions will be freshly prepared on the day of sedation session. Depending on the dosage calculated from the weight of each child, For children who will receive midazolam using the atomization device attached to a three-ml syringe, the child sitting reclined in knee-to-knee position. Half of the dose will be sprayed in the right nostril and the other half will be sprayed in the left nostril to double the absorptive surface area by short and quick puffs |
Timeline
- Start date
- 2022-11-10
- Primary completion
- 2023-08-30
- Completion
- 2023-08-30
- First posted
- 2023-05-31
- Last updated
- 2023-11-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05883150. Inclusion in this directory is not an endorsement.